News
European Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide ...
EU approves AstraZeneca’s Calquence in combo with venetoclax, with or without obinutuzumab to treat adult patients with previously untreated CLL: Cambridge, UK Saturday, June 7, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback